2002
DOI: 10.1172/jci200215078
|View full text |Cite
|
Sign up to set email alerts
|

CD19-dependent B lymphocyte signaling thresholds influence skin fibrosis and autoimmunity in the tight-skin mouse

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
72
0
3

Year Published

2004
2004
2020
2020

Publication Types

Select...
9

Relationship

3
6

Authors

Journals

citations
Cited by 66 publications
(81 citation statements)
references
References 32 publications
(60 reference statements)
6
72
0
3
Order By: Relevance
“…The overexpression of CD19 appears to be partly based on genetic polymorphism of CD19 gene itself (9), suggesting that CD19 may be causally involved in a proportion of patients. Such a possibility is supported by the TSK mouse model, in which introduction of the CD19 deficiency resulted not only in the reduction of autoantibody production and hyper-gammaglobulinemia but also in skin fibrosis (8). Our present study suggested that CD22 polymorphism may also be causally involved in a small proportion of patients.…”
Section: Discussionsupporting
confidence: 62%
“…The overexpression of CD19 appears to be partly based on genetic polymorphism of CD19 gene itself (9), suggesting that CD19 may be causally involved in a proportion of patients. Such a possibility is supported by the TSK mouse model, in which introduction of the CD19 deficiency resulted not only in the reduction of autoantibody production and hyper-gammaglobulinemia but also in skin fibrosis (8). Our present study suggested that CD22 polymorphism may also be causally involved in a small proportion of patients.…”
Section: Discussionsupporting
confidence: 62%
“…Comparison with the scleroderma gene expression pattern demonstrated a strong contribution of the B lymphocyte signature, suggesting a potential role for B cells in the pathogenesis of scleroderma (Whitfield et al, 2003). Consistent with this result, B cells also appear to have a pathogenic role in the tight-skin mouse model of scleroderma (Saito et al, 2002). These studies support the idea that rituximab, an anti-CD20 monoclonal antibody which targets B cells, may be useful in the treatment of scleroderma.…”
Section: Three Examples Of Gene Module Analysissupporting
confidence: 69%
“…While B cells and BCR signaling have been demonstrated to be integral to the pathogenesis in some forms of autoimmunity, such as systemic sclerosis, Bregs and efficient BCR signaling have also been shown to be protective. 11,12 In the EAE model, CD19-deficient mice develop a severe, nonremitting form of autoimmunity, suggesting that fully functional BCR signaling is required for adequate B cellmediated control of autoimmunity. 13,14 Furthermore, CD22 −/− mice lack the CD22-mediated counter-regulation of the BCR, and these animals show an increased number of immature B cells, which may have regulatory functions.…”
Section: Role Of Antigen-specificity and Bcr Signaling In Breg Funcmentioning
confidence: 99%